GlassScriptPhysician profile
Crystal Deno
NPI 1245906171
$541.03
in general payments reported to CMS, 2019-2025
10 companies · $21.41 in 2025
The $21.41 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.85 · 2022: $145 · 2023: $13.36 · 2024: $278 · 2025: $21.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.35 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $61.26 | 2024 | |
| Pfizer INC. | $44.25 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.35 | 2024 | Relistor |
| Tersera Therapeutics LLC | $38.98 | 2024 | Prialt |
| Neurocrine Biosciences, INC. | $21.41 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $21.36 | 2024 | Austedo Xr |
| Lundbeck LLC | $20.80 | 2024 | Vyepti |
| Genentech USA, INC. | $16.64 | 2022 | |
| Novo Nordisk INC | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Deno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.